Cargando…
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series
BACKGROUND: Immune checkpoint inhibition is part of standard systemic management for many advanced malignancies. Toxicities from this treatment approach are unpredictable, though usually reversible with management per established guidelines. Some patients suffer major morbidity and treatment-related...
Autores principales: | Arora, Puja, Talamo, Laura, Dillon, Patrick, Gentzler, Ryan D., Millard, Trish, Salerno, Michael, Slingluff, Craig L., Gaughan, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513476/ https://www.ncbi.nlm.nih.gov/pubmed/32983574 http://dx.doi.org/10.1186/s40959-020-00076-6 |
Ejemplares similares
-
Microbiome influencers of checkpoint blockade–associated toxicity
por: Wang, Yinghong, et al.
Publicado: (2023) -
Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
por: Dougan, Michael
Publicado: (2017) -
A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim
por: Mort, Joseph, et al.
Publicado: (2022) -
Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016) -
Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)